The Pharma-Psych Nexus

The expression pharma-psych nexus (Williams, Katz, and Martin 2011) has been used to capture the spread of psychopharmaceutical products that target the brain’s chemistry.

This includes, among others, the commercialization of selective serotonin reuptake inhibitors (SSRIs) for depression and anxiety-related disorders and of psychostimulants like methylphenidate (well known under the trade name Ritalin) for ADHD as well as the use of these and other substances, such as modafinil (indicated for the treatment of narcolepsy), for recreational and enhancement purposes.

Vidal, Fernando and Ortega, Francisco. Being Brains: Making the Cerebral Subject (Forms of Living)....

Download the article by Williams, Katz and Martin below:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Image source

Methylphenidate (Ritalin)

Image source